Literature DB >> 24033845

Clinical and cytogenetic results of a large series of amniocentesis cases from Turkey: report of 6124 cases.

Zeynep Ocak1, Tülay Özlü, Hasan Fehmi Yazıcıoğlu, Osman Özyurt, Mehmet Aygün.   

Abstract

AIM: The aim of this study was to document the clinical and cytogenetic results of a large series of amniocentesis (AS) cases from Turkey.
MATERIAL AND METHODS: Second-trimester amniocentesis cases performed in Suleymaniye Maternity Hospital for Research and Training between January 2007 and December 2011 were included.
RESULTS: During this period, 6124 AS were performed. Indications were increased risk in maternal serum screening (MSS) (56%), advanced maternal age (29%) and pathologic ultrasound finding (11.5%). Most frequent MSS abnormality was abnormal triple test result (58%). Overall culture success rate was 98.8%. Chromosomal abnormality was detected in 215 (3.6%) of the 6052 cytogenetic results (74.9% numerical, 25.1% structural). Most frequent numerical chromosomal abnormality was trisomy 21 (61.9%). Clinically insignificant polymorphisms were the most frequent structural changes (n = 571). Most frequent polymorphism was increase in heterochromatin region in the 1st chromosome (n = 158). Advanced maternal age had a positive predictive value of 5.2%. Among the MSS tests, the combined test had the highest positive predictive value (5.2%).
CONCLUSIONS: In our study, abnormal MSS (and among these, abnormal triple test result) was the most frequent indication for amniocentesis. Our overall culture success rate was 98.8%. Frequency of major chromosomal abnormality was 3.2% and trisomy 21 was the most frequent abnormality.
© 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  Down syndrome; amniocentesis; chromosomal abnormality; prenatal diagnosis

Mesh:

Year:  2013        PMID: 24033845     DOI: 10.1111/jog.12144

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  7 in total

1.  The assessment of combined karyotype analysis and chromosomal microarray in pregnant women of advanced maternal age: a multicenter study.

Authors:  Ye Shi; Jun Ma; Ying Xue; Jing Wang; Bin Yu; Ting Wang
Journal:  Ann Transl Med       Date:  2019-07

2.  Influence of place of residence on indications for genetic amniocentesis in the Pomeranian region of Poland before and after introduction of the Prenatal Screening Program in 2008.

Authors:  Katarzyna Ciach; Małgorzata Swiatkowska-Freund; Krzysztof Preis
Journal:  Med Sci Monit       Date:  2014-05-02

3.  Fission Yeast Methylenetetrahydrofolate Reductase Ensures Mitotic and Meiotic Chromosome Segregation Fidelity.

Authors:  Kim Kiat Lim; Hwei Yee Teo; Yuan Yee Tan; Yi Bing Zeng; Ulysses Tsz Fung Lam; Mahesh Choolani; Ee Sin Chen
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

4.  New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age.

Authors:  Yiming Chen; Xue Wang; Liyao Li; Sha Lu; Zhifen Zhang
Journal:  BMC Pregnancy Childbirth       Date:  2020-12-14       Impact factor: 3.007

5.  Follow-up in Patients With Non-invasive Prenatal Screening Failures: A Reflection on the Choice of Further Prenatal Diagnosis.

Authors:  Sha Liu; Hongqian Liu; Jianlong Liu; Ting Bai; Xiaosha Jing; Tianyu Xia; Cechuan Deng; Yunyun Liu; Jing Cheng; Xiang Wei; Lingling Xing; Yuan Luo; Quanfang Zhou; Qian Zhu
Journal:  Front Genet       Date:  2021-05-19       Impact factor: 4.599

6.  Evaluation of the results of patients who applied to the Çukurova University, Medical Genetics Department for prenatal diagnosis and determination of genetic counseling principles

Authors:  Sevcan Tuğ Bozdoğan; Selim Büyükkurt; Sinem Özer; Atıl Bişgin
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

7.  20-year experience on prenatal diagnosis in a reference university medical genetics center in Turkey

Authors:  Burak Durmaz; Hilmi Bolat; Zehra Cengisiz; Fuat Akercan; Tuba Sözen Türk; Erhan Parıltay; Aslı Ece Solmaz; Mert Kazandı; Emin Karaca; Asude Durmaz; Ayça Aykut; Sermet Sağol; Haluk Akın; Ferda Özkınay; ÖzgÜr Çoğulu
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.